NCT01302704

Brief Summary

The purpose of this study is to demonstrate if Proton Pump Inhibitors (PPI's) decrease blood levels of 25-Hydroxyvitamin D (25-OH Vitamin D).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2012

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 24, 2011

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 25, 2013

Status Verified

November 1, 2013

Enrollment Period

1.6 years

First QC Date

February 17, 2011

Last Update Submit

November 21, 2013

Conditions

Keywords

Vitamin DProton Pump Inhibitors

Outcome Measures

Primary Outcomes (1)

  • Change in 25-OH Vitamin D Blood Levels over 60 days

    Subjects will have their baseline 25-OH Vitamin D levels drawn. They will then take Omeprazole 20mg for 60 consecutive days, then have blood samples drawn to measure their 25-OH Vitamin D.

    2 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We are recruiting healthy volunteers (DoD beneficiaries) whom are at least 18 years of age from the Nellis Air Force Base population. Subjects will not have any concomitant medical conditions, been diagnosed with any chronic illness that requires regular monitoring by a health care provider, have been living in Las Vegas for at least 3 months, and not be on any medications. Some subjects may be the PI or AI's patients. No special populations will be recruited.

You may qualify if:

  • Tricare Insurance Beneficiary (military insurance) receiving care at Nellis AFB
  • Male and Female (DoD beneficiaries) at least 18 years of age and have lived in the Las Vegas area for at least 3 months.

You may not qualify if:

  • Subjects less than 18 years of age.
  • Subjects that have known malabsorption conditions.
  • OH Vitamin D less than 10
  • Pregnancy
  • Non English speaking
  • Taking any prescription medication or over the counter antacids
  • Vitamin d supplements (excluding multivitamin supplements due to relatively low dose of vitamin D)
  • Any medical condition that requires regular monitoring by health care provider

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mike O'Callaghan Federal Hospital

Nellis Air Force Base, Nevada, 89191, United States

Location

Study Officials

  • Roger Piepenbrink, D.O.

    Michael O'Callaghan Federal Hospital/Nellis Air Force Base

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2011

First Posted

February 24, 2011

Study Start

April 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 25, 2013

Record last verified: 2013-11

Locations